Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by inducible and constitutive cytochrome P450 enzymes in rats

https://doi.org/10.1016/0003-9861(92)90124-FGet rights and content

Abstract

The tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) induces tumor formation in the liver, lung, nasal cavity, and pancreas of rats. Metabolic activation is required for the tumorigenicity of this compound. The involvement of cytochrome P450 enzymes in NNK bioactivation was investigated in rats by studies with chemical inducers and antibodies against P450s. Liver microsomal enzymes catalyzed the formation of 4-oxo-1-(3-pyridyl)-1-butanone (keto aldehyde), 4-hydroxy-1-(3-pyridyl)-1-butanone (keto alcohol), 4-(methylnitrosamino)-1-(3-pyridyl-N-oxide)-1-butanone (NNK-N-oxide), and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) from NNK. When the activity was expressed on a per nanomole P450 basis, treatments of rats with 3-methylcholanthrene (MC), phenobarbital (PB), pregnenolone 16-α-carbonitrile (PCN), Aroclor 1254 (AR), safrole (SA), and isosafrole (ISA) increased the keto aldehyde formation in liver microsomes 2.0-, 2.4-, 3.8-, 2.5-, 2.1-, and 1.8-fold, respectively; PB, AR, SA, and ISA increased the keto alcohol formation 1.7-, 1.3-, 2.0-, and 1.3-fold, respectively. The extents of induction were more pronounced when expressed on a per milligram protein basis, due to the higher microsomal P450 contents in the induced microsomes. The formation of NNK-N-oxide was markedly increased by PB and PCN and slightly increased by AR, SA, and ISA. However, the formation of NNAL, the major metabolite due to carbonyl reduction, was not increased by the treatments but was decreased by AR, ISA, and acetone (AC). The kinetic parameters of NNK metabolism by control, MC-, PB-, and PCN-induced liver microsomes were obtained. A panel of monoclonal (anti-1A1, -2B1, -2C11, and -2E1) and polyclonal (anti-1A2, -2A1, and -3A) antibodies were used to assess the involvement of constitutive hepatic P450 enzymes in NNK metabolism. Keto aldehyde formation was inhibited by anti-1A2 and anti-3A (about 15%) but not by others; the formation of keto alcohol was inhibited by anti-1A2, anti-2A1, and anti-3A (by 13–26%). In incubations with lung microsomes, the formation of keto aldehyde, keto alcohol, NNK-N-oxide, and NNAL were observed. With nasal mucosa microsomes, however, only keto aldehyde and keto alcohol formation were appreciable. SA and AC significantly decreased NNK metabolism in lung and nasal mucosa microsomes. Furthermore, SA inhibited the NNK oxidative metabolism in lung and nasal mucosa microsomes in vitro. AC significantly inhibited the NNK oxidative metabolism in lung microsomes in vitro, but not in nasal mucosa microsomes. The present results demonstrate the important role of P450 enzymes in the metabolism of NNK. Several P450 isozymes can catalyze the oxidation of NNK with different but overlapping regioselectivities and P450 inducers affect the metabolism of NNK differently in the liver, lung, and nasal mucosa.

References (30)

  • T.D. Porter et al.

    J. Biol. Chem

    (1991)
  • F.P. Guengerich

    J. Biol. Chem

    (1991)
  • T. Omura et al.

    J. Biol. Chem

    (1964)
  • S.S. Park et al.

    Biochem. Pharmacol

    (1986)
  • P.E. Thomas et al.

    J. Biol. Chem

    (1983)
  • L.M. Reik et al.

    Arch. Biochem. Biophys

    (1985)
  • L.M. Reik et al.

    J. Immunol. Methods

    (1987)
  • P.E. Thomas et al.

    J. Biol. Chem

    (1983)
  • L.A. Loeb et al.

    Cancer Res

    (1984)
  • S.S. Hecht et al.

    Carcinogenesis (London)

    (1988)
  • S.S. Hecht et al.

    Cancer Res

    (1980)
  • D. Hoffmann et al.

    Cancer Res

    (1985)
  • F.J. Gonzalez

    Pharmacol. Rev

    (1989)
  • F.P. Guengerich et al.

    Chem. Res. Toxicol

    (1991)
  • C.L. Crespi et al.

    Carcinogenesis (London)

    (1991)
  • Cited by (0)

    This study was supported by NIH Grants CA-46535 and CA-37037 and NIEHS Center Grant ES-05022.

    View full text